potentially and borderline resectable pancreatic cancer
Conditions
Interventions
To investigate the frequency of histological curative resection following chemoradiation using Gemcitabine and TS-1in patients with potentially resectable pancreatic cancer
Sponsors
Kansai Medical University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with Histo-cytologically confirmed pancreatic cancer 2.Patients who have not undergone chemo and/or radiotherapy 3.Patients with radiologically defined patentially resectable pancreatic cancer 4.Patients with no metastatic disease confirmed by staging laparoscopy 5.Patients with Performance status of 0/1 6.Patients with sustained organ function 7.Patients with potentially resectable pancreatic cancer by CT following neoadjuvant chemoradiation 8.Patients who received informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with other active cancers 2) Patients with watery diarrhea 3) Intractable pleural and pericardical effusion, or ascites 4) Severe co-morbid diseases 5) Pregnancy or insufficient contraception 6) Past history of severe drug-allergy 7) Active bacterial or viral infection 8) younger than 20 years old or older than 90 years old. 9) No written informed consent of the patients 10) Pregnancy or insufficient contraception 11) HIV infection 12) Doubtful understanding or contractual capacity of the patient 13) Patients seems inadequate for this study by investigator(s)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of radical resection (R0) | — |
Countries
Japan
Contacts
Public ContactSohei SATOI MD
Kansai Medical University Hospita Department of Surgery
Outcome results
None listed